PolyPid Net Working Capital vs Long Term Debt Analysis
| PYPD Stock | USD 4.32 0.12 2.70% |
PolyPid financial indicator trend analysis is much more than just breaking down PolyPid prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PolyPid is a good investment. Please check the relationship between PolyPid Net Working Capital and its Long Term Debt accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.
Net Working Capital vs Long Term Debt
Net Working Capital vs Long Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PolyPid Net Working Capital account and Long Term Debt. At this time, the significance of the direction appears to have no relationship.
The correlation between PolyPid's Net Working Capital and Long Term Debt is 0.02. Overlapping area represents the amount of variation of Net Working Capital that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of PolyPid, assuming nothing else is changed. The correlation between historical values of PolyPid's Net Working Capital and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Working Capital of PolyPid are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Net Working Capital i.e., PolyPid's Net Working Capital and Long Term Debt go up and down completely randomly.
Correlation Coefficient | 0.02 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Net Working Capital
Long Term Debt
Long-term debt is a debt that PolyPid has held for over one year. Long-term debt appears on PolyPid balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on PolyPid balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.Most indicators from PolyPid's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PolyPid current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.At present, PolyPid's Enterprise Value is projected to decrease significantly based on the last few years of reporting.
PolyPid fundamental ratios Correlations
Click cells to compare fundamentals
PolyPid Account Relationship Matchups
High Positive Relationship
High Negative Relationship
PolyPid fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 33.8M | 75.8M | 44.2M | 26.0M | 15.4M | 25.8M | |
| Other Current Liab | 998K | 1.7M | 3.4M | (31K) | 2.0M | 1.4M | |
| Total Current Liabilities | 2.6M | 2.9M | 7.8M | 8.6M | 7.3M | 4.0M | |
| Total Stockholder Equity | 30.9M | 72.8M | 36.2M | 5.9M | (2.1M) | (2.2M) | |
| Property Plant And Equipment Net | 6.1M | 5.9M | 8.8M | 11.7M | 9.2M | 5.3M | |
| Net Debt | (3.9M) | (4.3M) | (9.8M) | 5.2M | 6.2M | 6.5M | |
| Retained Earnings | (93.3M) | (132.3M) | (174.6M) | (214.4M) | (238.3M) | (226.4M) | |
| Accounts Payable | 1.6M | 974K | 4.1M | 1.1M | 772K | 1.3M | |
| Cash | 3.9M | 4.3M | 9.8M | 8.6M | 5.6M | 5.8M | |
| Non Current Assets Total | 6.4M | 28.3M | 9.4M | 11.8M | 9.3M | 7.8M | |
| Non Currrent Assets Other | 31K | 22.2M | 423K | 99K | 87K | 82.7K | |
| Other Assets | 230K | 22.8M | 663K | 99K | 113.9K | 108.2K | |
| Cash And Short Term Investments | 26.6M | 44.5M | 32.2M | 12.6M | 5.6M | 5.3M | |
| Net Receivables | 42K | 139K | 118K | 298K | 342.7K | 359.8K | |
| Common Stock Shares Outstanding | 13.3M | 319.4K | 624.1K | 647.6K | 1.4M | 1.8M | |
| Liabilities And Stockholders Equity | 33.8M | 75.8M | 44.2M | 26.0M | 15.4M | 25.8M | |
| Non Current Liabilities Total | 251K | 193K | 199K | 11.5M | 10.2M | 9.7M | |
| Other Current Assets | 399K | 2.3M | 25.0M | 1.1M | 458K | 435.1K | |
| Other Stockholder Equity | 124.2M | 205.1M | 210.8M | 220.3M | 236.2M | 248.0M | |
| Total Liab | 2.8M | 3.1M | 8.0M | 20.1M | 17.5M | 24.1M | |
| Total Current Assets | 27.4M | 47.6M | 34.8M | 14.2M | 6.1M | 5.8M | |
| Accumulated Other Comprehensive Income | (766K) | (1.2M) | (106.4M) | (3.1M) | (2.8M) | (3.0M) | |
| Property Plant Equipment | 6.1M | 5.9M | 8.8M | 11.7M | 13.4M | 14.1M | |
| Other Liab | 251K | 193K | 199K | 2.8M | 3.3M | 3.4M | |
| Net Tangible Assets | (87.6M) | 72.8M | 36.2M | 5.8M | 6.7M | 7.0M | |
| Short Term Investments | 14.0M | 0.0 | 22.7M | 40.2M | 22.4M | 4.0M | |
| Non Current Liabilities Other | 251K | 193K | 199K | 174K | 398K | 273.2K | |
| Net Invested Capital | 30.9M | 72.8M | 36.2M | 17.5M | 8.3M | 8.7M | |
| Net Working Capital | 24.8M | 44.3M | 27.0M | 5.6M | (1.2M) | (1.2M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for PolyPid Stock analysis
When running PolyPid's price analysis, check to measure PolyPid's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PolyPid is operating at the current time. Most of PolyPid's value examination focuses on studying past and present price action to predict the probability of PolyPid's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PolyPid's price. Additionally, you may evaluate how the addition of PolyPid to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is PolyPid's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PolyPid. If investors know PolyPid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PolyPid listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (16.99) | Return On Assets (0.69) | Return On Equity (12.79) |
The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PolyPid's value and its price as these two are different measures arrived at by different means. Investors typically determine if PolyPid is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PolyPid's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.